QuantiFERON®-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor α therapy
N. Desai, Y. Raste,
Y. Raste
Respiratory Medicine, St. Helier University Hospital NHS Trust, Wrythe Lane, Carshalton, Surrey SM5 1AA, U.K.E-mail: [email protected]
Search for more papers by this author N.T. Cooke,
N.T. Cooke
Respiratory Medicine, St. Helier University Hospital NHS Trust, Wrythe Lane, Carshalton, Surrey SM5 1AA, U.K.E-mail: [email protected]
Search for more papers by this author C.C. Harland,
C.C. Harland
Departments of Dermatology
Search for more papers by this author
N. Desai, Y. Raste,
Y. Raste
Respiratory Medicine, St. Helier University Hospital NHS Trust, Wrythe Lane, Carshalton, Surrey SM5 1AA, U.K.E-mail: [email protected]
Search for more papers by this author N.T. Cooke,
N.T. Cooke
Respiratory Medicine, St. Helier University Hospital NHS Trust, Wrythe Lane, Carshalton, Surrey SM5 1AA, U.K.E-mail: [email protected]
Search for more papers by this author C.C. Harland,
C.C. Harland
Departments of Dermatology
Search for more papers by this author
First published: 18 February 2008
No abstract is available for this article.
References
- 1
NICE.
Etanercept and efaluzimab for the treatment of adults with psoriasis. NICE technology appraisal guidance. TA103, July 2006. Available at: http://www.nice.org.uk/TA103 (accessed 3 January 2008).
- 2
Omerod LP,
Milburn HJ,
Gillespie J
et al.
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment. British Thoracic Society Standards of Care Committee.
Thorax
2005; 60: 800–5.
- 3
Mori T,
Sakatani M,
Yamagishi F
et al.
Specific detection of tuberculosis infection: an interferon-γ based assay using new antigens.
Am J Resp Crit Care Med
2004; 170: 59–64.
- 4
Lein AD,
Fordham von Reyn C,
Ravn P
et al.
Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis.
Clin Diagn Lab Immunol
1999; 6: 606–9.
- 5
Richeldi L.
An update on the diagnosis of tuberculosis infection.
American J Resp Crit Care Med
2006; 174: 736–42.
- 6
Mazurek GH,
Jereb J,
Lobue P
et al.
Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.
MMWR Recomm Rep
2005; 16: 49–55.
- 7
Pratt A,
Nicholl K,
Kay L.
Uses of the QuantiFERON-TB Gold test as part of a screening programme in patients with RA under consideration for treatment with ant-TNF-α agents: the Newcastle (UK) experience.
Rheumatology
2007; 46: 1035–6.
